R EFERENCES BIBLIOGRAPHIQUES

Les références bibliographiques sont listées, selon le système « Harvard » par ordre alphabétique et non par ordre d’apparition dans le texte.

Les références bibliographiques des publications COLOR1 et COLOR2, si elles ne sont pas reprises dans le texte, ne sont pas incluses dans ce chapitre.

 Acton QA. Issues in Cancer Epidemiology and Research. Atlanta: Scholarly, 2011.  Adakan Y, Taskoparan M, Cekin AH, Duman A, Harmandar F, Taskin V, Yilmaz U,

Yesil B. Implementation of screening colonoscopy amongst first-degree relatives of patients with colorectal cancer in Turkey: a cross-sectional questionnaire based survey. Asian Pac J Cancer Prev. 2014;15:5523-5528.

 Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES). Conférence de consensus. Prévention, dépistage et prise en charge des cancers du colon. 1998. Paris: ANAES. Gastroenterol Clin Biol. 1998;22 :205-218.

 Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES). Recommandations pour la pratique clinique. Endoscopie digestive basse : indications en dehors du dépistage en population ANAES 2004. http://www.has- sante.fr/portail/upload/docs/application/pdf/endoscopie_2004_recommandations_mise _en_forme_2006.pdf (visité le 02/11/2016).

 Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES).Clinical practice guidelines. Indications for lower gastrointestinal endoscopy (excluding population screening). ANAES, 2004.

http://www.has-sante.fr/portail/upload/docs/application/pdf/Endoscopy_guidelines.pdf (visité le 02/11/2016).

 Agence Nationale d'Accréditation et d'Evaluation en Santé (ANAES). Endoscopie digestive basse. Indications en dehors du dépistage en population. Recommandations pour la pratique clinique - Avril 2004. Oncologie. 2005;7:70-75 et 141-145.

 Ait Ouakrim D, Boussioutas A, Lockett T, Winship I, Giles GG, Flander LB, Keogh L, Hopper JL, Jenkins MA. Screening practices of unaffected people at familial risk of colorectal cancer. Cancer Prev Res. 2012;5:240-247.

 Ait Ouakrim D, Lockett T, Boussioutas A, Hopper JL, Jenkins MA. Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis. Fam Cancer. 2013a;12:459-472.

 Ait Ouakrim D, Lockett T, Boussioutas A, Keogh L, Flander LB, Hopper JL, Jenkins MA. Screening Participation Predictors for People at Familial Risk of Colorectal Cancer. A Systematic Review. Am J Prev Med. 2013b;44:496-506.

 Ait Ouakrim D, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, Bota M, Jenkins MA, Bleiberg H, Autier P. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ. 2015;351.

2015;38:837-850.

 Benson VS, Julietta Patnick J, Davies AK Nadel MR, Smith RA, Atkin WS; International Colorectal Cancer Screening Network. Colorectal cancer screening: a comparison of 35 initiatives in 17 countries. Int. I. Cancer. 2008;122:1357-1367.  Bleiker EM, Menko FH, Taal BG Kluijt I, Wever LD, Gerritsma MA, Vasen HF,

Aaronson NK. Screening behavior of Individuals at High Risk for Colorectal Cancer. Gastroenterology. 2005;128:280-287.

 Boonyasiriwat W, Hung M, Hon SD, Tang P, Pappas LM, Burt RW, Schwartz MD, Stroup AM, Kinney AY. Intention to undergo colonoscopy screening among relatives of colorectal cancer cases: a theory-based model. Ann Behav Med. 2014;47:280-291.  Bouvier AM, Manfredi S, Lejeune C. L'histoire naturelle du cancer colorectal

revisitée. Gastroenterol Clin Biol. 2002;26:56-61.

 Brenner H, Altenhofen L, Stock C, Hoffmeister M. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany. Clin Gastroenterol Hepatol 2015;13:717–723.

 Bridou M, Aguerre C, Gimenes G, Kubiszewski V, Le Gall A, Potard C, Sorel O, Reveillere C. Psychological Barriers and Facilitators of Colorectal Cancer Screening: A French Qualitative Study. Health Psychol Res. 2013;1:e22.

 Bronner K, Mesters I, Weiss-Meilik A, Geva R, Rozner G, Strul H, Inbar M, Halpern Z, Kariv R. Determinants of adherence to screening by colonoscopy in individuals with a family history of colorectal cancer. Patient Educ Couns. 2013a;93:272-281.  Bronner K, Mesters I, Weiss-Meilnik A, Geva R, Rozner G, Strul H, Inbar M, Halpern

Z, Kariv R. Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer? Fam Cancer. 2013b;12:629- 637.

 Bujanda L, Sarasqueta C, Zubiaurre L, Cosme A, Muñoz C, Sánchez A, Martín C, Tito L, Piñol V, Castells A, Llor X, Xicola RM, Pons E, Clofent J, de Castro ML, Cuquerella J, Medina E, Gutierrez A, Arenas JI, Jover R; EPICOLON Group. Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut. 2007;56:1714-1718.

 Bulliard JL, Levi F, Ducros C. Dépistage organisé du cancer colorectal : défis et enjeux pour un essai pilote en Suisse. Rev Med Suisse. 2012;8:1464–1467.

 Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer. 2006;42:216-227.  Center MM, Jemal A, Smith RA, Ward E. Worldwide variations in colorectal cancer.

 Champion VL & Skinner CS. The health belief model. In Glanz K, Rimer BK, and Viswanath K. Health Behavior and Health Education. Theory, Research and Practice. San Fransisco: Wiley & Sons, 2008.

 Chastek B, Kulakodlu M, Valluri S, Seal B. Impact of metastatic colorectal cancer stage and number of treatment courses on patient health care costs and utilization. Postgrad Med. 2013;125:73-82.

 Christy SM, Perkins SM, Tong Y, Krier C, Champion VL, Skinner CS, Springston JK, Imperiale TF, Rawl SM. Promoting colorectal cancer screening discussion: a randomized controlled trial. Am J Prev Med. 2013;44:325-329.

 Chouhdari A, Yavari P, Pourhoseingholi MA, Sohrabi MR. Association Between Socioeconomic Status and Participation in Colonoscopy Screening Program in First Degree Relatives of Colorectal Cancer Patients. Iran J Cancer Prev. 2016;9:e4809.  Clerc L, Jooste V, Lejeune C, Schmitt B, Arveux P, Quantin C, Faivre J, Bouvier AM.

Cost of care of colorectal cancers according to health care patterns at diagnosis in France. Eur J Health Econ 2008;9:361-367.

 Codori AM, Petersen GM, Miglioretti DL, Boyd P. Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med. 2001;33:128-136.

 Colombo L, Corti G, Magri F Marocchi A, Brambilla P, Crespi C, Manieri L, Ghezzi S, Giannone D, Merlino L, Mocarelli P. Results of a pilot study of endoscopic screening of first degree relatives of colorectal cancer patients in Italy. J Epidemiol Community Health. 1997;51: 453-458.

 Com-Ruelle L, Lucas-Gabrielli V, Renaud T. Le coût du cancer du côlon en Ile-de- France. Bulletin d’information en économie de la santé. 2005;98.

 Cottet V, Pariente A, Nalet B, Lafon J, Milan C, Olschwang S, Bonaiti-Pellié C, Faivre J, Bonithon-Kopp C; ANGH Group. Colonoscopic screening of first-degree relatives of patients with large adenomas: increased risk of colorectal tumors. Gastroenterology. 2007;133:1086-1092.

 Courtney RJ, Paul CL, Carey ML, Sanson-Fisher RW, Macrae FA, D'Este C, Hill D, Barker D, Simmons J. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients. BMC Cancer. 2013;13:13.

 Creswell JW, Plano-Clark VO. Designing and conducting mixed methods research. Thousand Oaks: Sage, 2007.

 Dancourt V, Faivre J. Épidémiologie et dépistage des cancers colorectaux. Rev Prat. 2004;54:135-142.

 Denis B, Perrin P, Cailleret AF, Guth F, Ruetsch M, Strentz P. Dépistage du CCR. Enquête auprès des médecins généralistes d’un département français. Gastroenterol Clin Biol. 2003;27:992-997.

 Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-386.

 Flander L, Speirs-Bridge A, Rutstein A, Niven H, Win AK, Ait Ouakrim D, Hopper JL, Macrae F, Keogh L, Gaff C, Jenkins M. Perceived Versus Predicted Risks of Colorectal Cancer and Self-Reported Colonoscopies by Members of Mismatch Repair Gene Mutation-Carrying Families Who Have Declined Genetic Testing. J Genet Couns. 2014;23:79-88.

 Frank D, Swedmark J, Grubbs L. Colon cancer screening in African American women. ABNF J 2004;15:67-70.

 Frohlich KL, Potvin L. Transcending the known in public health practice: the inequality paradox: the population approach and vulnerable populations. Am J Public Health. 2008;98:216-221.

 Garcia GH, Riechelmann RP, Hoff PM. Adherence to colonoscopy recommendations for first-degree relatives of young patients diagnosed with colorectal cancer. Clinics (Sao Paulo) 2015;70:696-699.

 Gili M, Roca M, Ferrer V, Obrador A, Cabeza E. Psychosocial factors associated with the adherence to a colorectal cancer screening program. Cancer Detect Prev. 2006;30:354-360.

 Gimeno García AZ, Quintero E, Nicolás Pérez D, Hernández M, JiménezSosa A. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening. Eur J Gastroenterol Hepatol. 2011;23:1165-1171.

 Gimeno-García AZ, Hernández-Álvarez-de-Buylla N, Nicolás-Pérez D, Carrillo M, Hernández G, Quintero E. Colorectal cancer screening in the familial risk population: Is colonoscopy still the strategy of choice? Gastroenterol Hepatol. 2016;39:352-360.  Gipsh K, Sullivan JM, Dietz EO. Health belief assessment regarding screening

colonoscopy. Gastroenterol Nurs. 2004;27:262-267.

 Glanz K, Grove J, Le Marchand L, Gotay C. Underreporting of family history of colon cancer: correlates and implications. Cancer Epidemiol Biomarkers Prev. 1999;8:635- 639.

 Glanz K, Steffen AD, Taglialatela LA. Effects of colon cancer risk counseling for first-degree relatives. Cancer Epidemiol Biomarkers Prev. 2007;16:1485-1491.

 Griffith KA, Passmore SR, Smith D, Wenzel J. African Americans with a family history of colorectal cancer: barriers and facilitators to screening. Oncol Nurs Forum. 2012;39:299-306.

 Harris MA, Byles JE. A survey of screening compliance among fırst degree relatives of people with colon cancer in New South Wales. J Med Screen. 1997;4:29–34.

 Harris MA, Treloar CJ, Byles JE. Colorectal cancer screening: discussions with first degree relatives. Aust N Z J Public Health. 1998;22:826-828.

 Harris MA, Byles JE, Cockburn, J D'Este C. A general practice-based recruitment strategy for colorectal cancer screening. Aust N Z J Public Health. 2000;24:441-443.  HAS : Dépistage et prévention du cancer colo-rectal. Actualisation du référentiel de

pratiques de l'examen périodique de santé. Juin 2013.

http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-

07/referentieleps_format2clic_kc_colon-vfinale_2013-07-24_16-05-56_103.pdf (visité le 02/11/2016).

 Hawe P, Potvin L. What is population health intervention research. Can J Public Health. 2009;100:Suppl I8-14.

 Hay JL, Ford JS, Klein D, Primavera LH, Buckley TR, Stein TR, Shike M, Ostroff JS. Adherence to colorectal cancer screening in mammography-adherent older women. J Behav Med. 2003;26:553-576.

 Hennink SD, van der Meulen-de Jong AE, Wolterbeek R, Crobach AS, Becx MC, Crobach WF, van Haastert M, Ten Hove WR, Kleibeuker JH, Meijssen MA, Nagengast FM, Rijk MC, Salemans JM, Stronkhorst A, Tuynman HA, Vecht J, Verhulst ML, de Vos Tot Nederveen Cappel WH, Walinga H, Weinhardt OK, Westerveld D, Witte AM, Wolters HJ, Cats A, Veenendaal RA, Morreau H, Vasen HF. Randomized Comparison of Surveillance Intervals in Familial Colorectal Cancer. J Clin Oncol. 2015;33:4188-4193.

 Heresbach D, Letard JC, Ingrand I, Bulois P, Benamouzig R, Lapuelle J, Costil V, Dalbies PA, Canard JM, Vaillant E, Pienkowski P, Ingrand P. Qui souhaite quoi et comment pour prévenir le cancer colorectal ? Une enquête prospective parmi les gastroentérologues en 2014. Acta Endosc. 2015.

 Hogan NM, Hanley M, Hogan AM, Sheehan M, McAnena OJ, Regan MP, Kerin MJ, Joyce MR. Awareness and uptake of family screening in patients diagnosed with colorectal cancer at a young age. Gastroenterol Res Pract. 2015:194931.

 Hubert A. Cancers et sciences de l’homme. Texte publié dans l'ouvrage sous la direction de Patrick Ben Soussan et Claire Julian-Reynier, Cancer et recherches en sciences humaines. 2008; Paris: Éditions ÉRÈS:17-32.

 Hunt LM, Rooney PS, Hardcastle JD, Armitage NC. Endoscopic screening of relatives of patients with colorectal cancer. Gut. 1998;42:71-75.

 INCa. Survie attendue des patients atteints de cancers en France : état des lieux. Col rapports et synthèses 2010.

2002;25:251-265.

 Janz NK, Becker MH. The Health Belief Model: a decade later. Health Educ Q. 1984;11:1-47.

 Janz NK, Wren PA, Schottenfeld D, Guire KE. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med. 2003;37:627-634.

 Jiménez JA, Jung B, Madlensky L. Physician-patient and patient-family communication after colonoscopy. Am J Gastroenterol. 2012;107:1288-1295.

 Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001;96:2992-3003.

 Johnson CM, Wei C, Ensor JE, Smolenski DJ, Amos CI, Levin B, Berry DA. Meta- analyses of colorectal cancer risk factors. Cancer Causes Control. 2013;24:1207- 1222.

 Kinney AY, Boonyasiriwat W, Walters ST, Pappas LM, Stroup AM, Schwartz MD, Edwards SL, Rogers A, Kohlmann WK, Boucher KM, Vernon SW, Simmons RG, Lowery JT, Flores K, Wiggins CL, Hill DA, Burt RW, Williams MS, Higginbotham JC. Telehealth personalized cancer risk communication to motivate colonoscopy in relatives of patients with colorectal cancer: the family CARE Randomized controlled trial. J Clin Oncol. 2014;32:654-662.

 Kivits J, Fournier C, Mino JC, Frattini MO, Winance M, Lefève C, Robelet M. Jalons pour une recherche interdisciplinaire en santé et en sciences humaines et sociales : apports d’un séminaire de recherche. Sante Publique. 2013;25:579-586.

 Koskan AM, Thomas-Purcell KB, Yu D, Quinn GP, Dessureault S, Shibata D, Jacobsen PB, Gwede CK. Discussion of First-Degree Relatives' Colorectal Cancer Risk: Survivors' Perspectives. Health Commun. 2014;29:782-790.

 Kreuter MW, Skinner CS. Tailoring: what's in a name? Health Educ Res. 2000;15:1-4.  Kreuter MW, Wray RJ. Tailored and targeted health communication: Strategies for

enhancing information relevance. Am J Health Behav. 2003;27(suppl 3):S227-S232.  Lawsin C, Duhamel K, Itzkowitz S, Brown K, Lim H, Jandorf L. An examination of

the psychosocial factors influencing colorectal cancer patients' communication of colorectal cancer patient risk with their siblings. Cancer Epidemiol Biomarkers Prev. 2009;18:2907-2912.

 Leone N, Voirin N, Roche L, Binder-Foucard F, Woronoff AS, Delafosse P, Remontet L, Bossard N, Uhry Z. Projection de l’incidence et de la mortalité par cancer en France métropolitaine en 2015 – novembre 2015.

 Lin OS, Gluck M, Nguyen M, Koch J, Kozarek RA. Screening patterns in patients with a family history of colorectal cancer often do not adhere to national guidelines. Dig Dis Sci. 2013;58:1841–1848.

 Ling BS, Schoen RE, Trauth JM, Wahed AS, Eury T, Simak DM, Solano FX, Weissfeld JL. Physicians encouraging colorectal screening: a randomized controlled trial of enhanced office and patient management on compliance with colorectal cancer screening. Arch Intern Med. 2009;169:47-55.

 Loi n° 2002-303 du 4 mars 2002 relative aux droits des malades et à la qualité du système de santé, JORF du 5 mars 2002

 Lowery JT, Marcus A, Kinney A, Bowen D, Finkelstein DM, Horick N, Garrett K, Haile R, Sandler R, Ahnen DJ. The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. Contemp Clin Trials. 2012;33:426-435.

 Lowery JT, Horick N, Kinney AY, et al. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev. 2014;23:601-610.  Lowery JT, Ahnen DJ, Schroy PC 3rd, Hampel H, Baxter N, Boland CR, Burt RW,

Butterly L, Doerr M, Doroshenk M, Feero WG, Henrikson N, Ladabaum U, Lieberman D, McFarland EG, Peterson SK, Raymond M, Samadder NJ, Syngal S, Weber TK, Zauber AG, Smith R. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer. 2016;122:2633-2645.

 Mack LA, Cook LS, Temple WJ, Carlson LE, Hilsden RJ, Paolucci EO. Colorectal cancer screening among fırst-degree relatives of colorectal cancer patients: benefıts and barriers. Ann Surg Oncol. 2009;16:2092–2100.

 Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V. Relatives of colorectal cancer patients. Factors associated with screening behavior. Am J Prev Med. 2003;25:187-194.

 Manne S, Markowitz A, Winaver S, Meropol NJ, Haller D, Rakowski W, Babb J, Jandorf L. Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol. 2002;21:3-15.

 Manne S, Markowitz A, Winawer S, Guillem J, Meropol NJ, Haller D, Jandorf L, Rakowski W, Babb J, Duncan T. Understanding intention to undergo colonoscopy among intermediate-risk siblings of colorectal cancer patients: a test of a mediational model. Prev Med. 2003;36:71-84.

 Manne SL, Coups EJ, Markowitz A, Meropol NJ, Haller D, Jacobsen PB, Jandorf L, Peterson SK, Lesko S, Pilipshen S, Winkel G. A randomized trial of generic versus tailored interventions to increase colorectal cancer screening among intermediate risk siblings. Ann Behav Med. 2009;37:207-217.

W, Blot WJ. Colonoscopy screening in African Americans and Whites with affected fırst-degree relatives. Arch Intern Med. 2008;168:625–631.

 National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER Stat Fact Sheets: Colon and Rectum Cancer.

http://seer.cancer.gov/statfacts/html/colorect.html(visité le 02/11/2016).

 Nakama H, Zhang B, Fukazawa K, Abdul Fattah AS. Family history of colorectal adenomatous polyps as a risk factor for colorectal cancer. Eur J Cancer. 2000;36:2111-2114.

 Ng SC, Lau JY, Chan FK, Suen BY, Tse YK, Hui AJ, Leung-Ki EL, Ching JY, Chan AW, Wong MC, Ng SS, To KF, Wu JC, Sung JJ. Risk of advanced adenomas in siblings of individuals with advanced adenomas: a cross-sectional study. Gastroenterology. 2016;150:608-616.

 Noar SM, Benac CN, Harris MS. Does Tailoring Matter? Meta-Analytic Review of Tailored Print Health Behavior Change Interventions. Psychol Bull. 2007;133:673– 693.

 Palmer RC, Emmons KM, Fletcher RH, Lobb R, Miroshnik I, Kemp JA, Bauer M. Familial risk and colorectal cancer screening health beliefs and attitudes in an insured population. Prev Med 2007;45:336-341.

 Percac-Lima S, Grant RW, Green AR, Ashburner JM, Gamba G, Oo S, Richter JM, Atlas SJ. A culturally tailored navigator program for colorectal cancer screening in a community health center: a randomized, controlled trial. J Gen Intern Med. 2009;24:211-217.

 Perencevich M, Ojha RP, Steyerberg EW, Syngal S. Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology. 2013;145:775-781.

 Plan cancer 2014-2019 : priorités et objectifs. http://www.e-cancer.fr/Plan- cancer/Plan-cancer-2014-2019-priorites-et-objectifs (visité le 02/11/2016).

 Ponchon T, Forestier S. Detect®. Evaluation d’outils d’aide au dépistage ciblé du CCR. Acta Endosc. 2005;35:675-680.

 Pope C, van Royen P, Baker R. Qualitative methods in research on healthcare quality. Qual Saf Health Care. 2002;11:148-152.

 Powe BD, Faulkenberry R, Harmond L. A review of intervention studies that seek to increase colorectal cancer screening among African-Americans. Am J Health Promot. 2010;25:92-99.

http://public.weconext.eu/trt5/2016-06-10/video_id_005/index.html#.WA3sYskXthd (visité le 02/11/2016).

 Quintero E, Carrillo M, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Díez-Fuentes ML, Abraira V. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening. Gastroenterology. 2014;147:1021-30.

 Quintero E, Carrillo M, Leoz ML, Cubiella J, Gargallo C, Lanas A, Bujanda L, Gimeno-García AZ, Hernández-Guerra M, Nicolás-Pérez D, Alonso-Abreu I, Morillas JD, Balaguer F, Muriel A; Oncology Group of the Asociación Española de Gastroenterología (AEG).) Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study. PLoS Med. 2016;13:e1002008.

 Rawl SM, Menon U, Champion VL, Foster JL, Skinner CS. Colorectal cancer screening beliefs. Focus groups with first-degree relatives. Cancer Pract. 2000;8:32- 37.

 Rawl SM, Champion VL, Scott LL, Zhou H, Monahan P, Ding Y, Loehrer P, Skinner CS. A randomized trial of two print interventions to increase colon cancer screening among first-degree relatives. Patient Educ Couns. 2008;71:215-227.

 Rawl SM, Skinner CS, Perkins SM, Springston J, Wang HL, Russell KM, Tong Y, Gebregziabher N, Krier C, Smith-Howell E, Brady-Watts T, Myers LJ, Ballard D, Rhyant B, Willis DR, Imperiale TF, Champion VL. Computer-delivered tailored intervention improves colon cancer screening knowledge and health beliefs of African-Americans. Health Educ Res. 2012;27:868-885.

 Rawl SM, Christy SM, Monahan PO, Ding Y, Krier C, Champion VL, Rex D. Tailored telephone counseling increases colorectal cancer screening. Health Educ Res. 2015;30:622-637.

 Rees G, Martin PR, Macrae FA. Screening participation in individuals with a family history of colorectal cancer : a review. Eur J Cancer Care. 2008;17:221-232.

 Registre des cancers Poitou-Charentes. http://medphar.univ-poitiers.fr/registre- cancers-poitou-charentes/ (visité le 02/11/2016).

 Richardson JL, Danley K, Mondrus GT, Deapen D, Mack T. Adherence to screening examinations for colorectal cancer after diagnosis in a fırst-degree relative. Prev Med. 1995;24:166–170.

 Rimer BK, Kreuter MW. Advancing tailored health communication: a persuasion and message effects perspective. J Commun. 2006;56(Suppl):S184-S201.

 Rosenstock IM. The Health Belief Model and Preventive Health Behavior. Health Educ Monogr. 1974;2:35-86.

 Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988;15:175-183.

 Skinner CS, Gupta S, Bishop WP, Ahn C, Tiro JA, Halm EA, Farrell D, Marks E, Morrow J, Julka M, McCallister K, Sanders JM, Rawl SM. Tailored information increases patient/physician discussion of colon cancer risk and testing: The Cancer Risk Intake System trial. Prev Med Rep. 2016;4:6-10.

 So WK, Choi KC, Chan DN, Shiu AT, Ho SS, Chan HY, Lam WW, Cheng KK, Goggins W, Chan CW. Colorectal cancer screening behaviour and associated factors among Chinese aged 50 and above in Hong Kong - A population-based survey. Eur J Oncol Nurs. 2012;16:413-418.

 Soler-Michel P, Courtial I, Bremond A. Participation secondaire des femmes au dépistage organize du cancer du sein. Revue de la littérature. Rev Epidemiol Sante Publique. 2005;53:549-567.

 Stegeman I, de Wijkerslooth TR, Stoop EM, van Leerdam ME, Dekker E, van Ballegooijen M, Kuipers EJ, Fockens P, Kraaijenhagen RA, Bossuyt PM. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer. Cancer Epidemiol. 2013;37:278-283.

 Stephens JH, Moore JWE. Can targeted intervention in CRC patients’relatives influence screening behaviour ? A pilot study. Colorectal Dis. 2008;10:179-186.  Strum WB. Colorectal Adenomas. N Engl J Med. 2016;374:1065-1075.

 Sulz MC, Meyenberger C, Sawatzki M. How is the increased risk of colorectal cancer in first-degree relatives of patients communicated? Eur J Gastroenterol Hepatol. 2014;26:222-228.

 Taouqi M, Ingrand I, Beauchant M, Migeot V, Ingrand P. Determinants of participation in colonoscopic screening by siblings of colorectal cancer patients in